Safer Prescribing and Care for the Elderly (SPACE): Cluster RCT in New Zealand General Practice

Not Applicable

Completed

• Conditions: High-risk prescribing; Public health; Public Health - Health service research

• Registration Number: ACTRN12618000034235
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-01-12
• Study Completion: 2020-07-29
• Last Update Posted: 10 May 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 21877

Inclusion Criteria

Patients (‘vulnerable patients’) will be included in the study if, at baseline, they fulfil one or more of the following inclusion criteria:
• Gastrointestinal risk factors (and not on gastro-protective medication) - Prior peptic ulcer; 75y and older; 65y and older prescribed aspirin; Prescribed oral anticoagulant
• Renal risk factors - Prescribed both renin-angiotensin system blocker and diuretic; chronic kidney disease (eGFR <60)
• Cardiac risk factors - Heart failure
Where patients have baseline assessments included in one study practice and then move to a second study practice before baseline assessment at the second practice, they will be included as study participants in the second practice only.

Exclusion Criteria

All patients fulfilling inclusion criteria in participating practices will be included. If children fulfil the inclusion criteria they will be included. This is highly unlikely given the inclusion criteria. No children were identified in audits during the feasibility study. We see no reason to exclude children - if children are receiving high-risk prescribing then it makes sense for doctors to review their medicines as well. The intervention is designed to promote medicines review.

Study & Design

• Study Type: Interventional
• Study Design: Not specified